Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study

from Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology · host Amer Ghavanini

Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study - Keywords: Myasthenia Gravis, Treatment, Neurology, Neuromuscular Disorders, Ravulizumab, Efgartigimod

Episode metadata supplied by the publisher feed · Published Jan 11, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study

0:00 14:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology?

This episode is 14 minutes long.

When was this Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology episode published?

This episode was published on January 11, 2025.

Can I download this Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!